175 related articles for article (PubMed ID: 21742898)
41. Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.
Majcher U; Urbaniak A; Maj E; Moshari M; Delgado M; Wietrzyk J; Bartl F; Chambers TC; Tuszynski JA; Huczyński A
Bioorg Chem; 2018 Dec; 81():553-566. PubMed ID: 30248507
[TBL] [Abstract][Full Text] [Related]
42. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
Duan Y; Liu W; Tian L; Mao Y; Song C
Curr Top Med Chem; 2019; 19(15):1289-1304. PubMed ID: 31210108
[TBL] [Abstract][Full Text] [Related]
43. The pharmacokinetics of a thiazole benzenesulfonamide beta 3-adrenergic receptor agonist and its analogs in rats, dogs, and monkeys: improving oral bioavailability.
Stearns RA; Miller RR; Tang W; Kwei GY; Tang FS; Mathvink RJ; Naylor EM; Chitty D; Colandrea VJ; Weber AE; Colletti AE; Strauss JR; Keohane CA; Feeney WP; Iliff SA; Chiu SH
Drug Metab Dispos; 2002 Jul; 30(7):771-7. PubMed ID: 12065435
[TBL] [Abstract][Full Text] [Related]
44. Interaction of a fluorescent derivative of paclitaxel (Taxol) with microtubules and tubulin-colchicine.
Han Y; Chaudhary AG; Chordia MD; Sackett DL; Perez-Ramirez B; Kingston DG; Bane S
Biochemistry; 1996 Nov; 35(45):14173-83. PubMed ID: 8916903
[TBL] [Abstract][Full Text] [Related]
45. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
[TBL] [Abstract][Full Text] [Related]
46. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
[TBL] [Abstract][Full Text] [Related]
47. Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin.
Sharma A; Sáez-Calvo G; Olieric N; de Asís Balaguer F; Barasoain I; Lamberth C; Díaz JF; Steinmetz MO
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640209
[TBL] [Abstract][Full Text] [Related]
48. A radioligand binding assay for antitubulin activity in tumor cells.
Young DH; Rubio FM; Danis PO
J Biomol Screen; 2006 Feb; 11(1):82-9. PubMed ID: 16314405
[TBL] [Abstract][Full Text] [Related]
49. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents.
Shi Q; Chen K; Morris-Natschke SL; Lee KH
Curr Pharm Des; 1998 Jun; 4(3):219-48. PubMed ID: 10197041
[TBL] [Abstract][Full Text] [Related]
50. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Kamath AV; Wang J; Lee FY; Marathe PH
Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
[TBL] [Abstract][Full Text] [Related]
51. Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site.
Massarotti A; Theeramunkong S; Mesenzani O; Caldarelli A; Genazzani AA; Tron GC
Chem Biol Drug Des; 2011 Dec; 78(6):913-22. PubMed ID: 22039890
[TBL] [Abstract][Full Text] [Related]
52. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
[TBL] [Abstract][Full Text] [Related]
53. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.
Yang J; Yan W; Yu Y; Wang Y; Yang T; Xue L; Yuan X; Long C; Liu Z; Chen X; Hu M; Zheng L; Qiu Q; Pei H; Li D; Wang F; Bai P; Wen J; Ye H; Chen L
J Biol Chem; 2018 Jun; 293(24):9461-9472. PubMed ID: 29691282
[TBL] [Abstract][Full Text] [Related]
54. 3-Aryl/Heteroaryl-5-amino-1-(3',4',5'-trimethoxybenzoyl)-1,2,4-triazoles as antimicrotubule agents. Design, synthesis, antiproliferative activity and inhibition of tubulin polymerization.
Romagnoli R; Prencipe F; Oliva P; Baraldi S; Baraldi PG; Brancale A; Ferla S; Hamel E; Bortolozzi R; Viola G
Bioorg Chem; 2018 Oct; 80():361-374. PubMed ID: 29986184
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents.
Carta D; Bortolozzi R; Sturlese M; Salmaso V; Hamel E; Basso G; Calderan L; Quintieri L; Moro S; Viola G; Ferlin MG
Eur J Med Chem; 2017 Feb; 127():643-660. PubMed ID: 27823884
[TBL] [Abstract][Full Text] [Related]
56. Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agents.
Romagnoli R; Baraldi PG; Brancale A; Ricci A; Hamel E; Bortolozzi R; Basso G; Viola G
J Med Chem; 2011 Jul; 54(14):5144-53. PubMed ID: 21663319
[TBL] [Abstract][Full Text] [Related]
57. Perturbation of microtubule polymerization by quercetin through tubulin binding: a novel mechanism of its antiproliferative activity.
Gupta K; Panda D
Biochemistry; 2002 Oct; 41(43):13029-38. PubMed ID: 12390030
[TBL] [Abstract][Full Text] [Related]
58. Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones.
Bortolozzi R; Carta D; Prà MD; Antoniazzi G; Mattiuzzo E; Sturlese M; Di Paolo V; Calderan L; Moro S; Hamel E; Quintieri L; Ronca R; Viola G; Ferlin MG
Eur J Med Chem; 2019 Sep; 178():297-314. PubMed ID: 31195171
[TBL] [Abstract][Full Text] [Related]
59. Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site.
Wu X; Wang Q; Li W
Anticancer Agents Med Chem; 2016; 16(10):1325-38. PubMed ID: 26899186
[TBL] [Abstract][Full Text] [Related]
60. Recent development and SAR analysis of colchicine binding site inhibitors.
Chen J; Liu T; Dong X; Hu Y
Mini Rev Med Chem; 2009 Sep; 9(10):1174-90. PubMed ID: 19817710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
